Preparing ductal epithelial organoids for high-spatial-resolution molecular profiling using mass spectrometry imaging

Brenda Bakker, Rianne D. W. Vaes, Merel R. Aberle, Tessa Welbers, Thomas Hankemeier, Sander S. Rensen, Steven W. M. Olde Damink, Ron M. A. Heeren

Published: 2022-02-17 DOI: 10.1038/s41596-021-00661-8

organoids

mass spectrometry imaging

3D morphological structure

gelatin embedding

molecular profiling

AI 解读

Deoxyfluorination of phenols for chemoselective18F-labeling of peptides

Stable isotope tracing to assess tumor metabolism in vivo

Measuring DNA modifications with the comet assay: a compendium of protocols

Detect-seq, a chemical labeling and biotin pull-down approach for the unbiased and genome-wide off-target evaluation of programmable cytosine base editors

A systems-level mass spectrometry-based technique for accurate and sensitive quantification of the RNA cap epitranscriptome

Spooling electrochemiluminescence spectroscopy: development, applications and beyond

Chronic, cortex-wide imaging of specific cell populations during behavior

Chromatin accessibility profiling by ATAC-seq

Global analysis of RNA-binding protein dynamics by comparative and enhanced RNA interactome capture

Pooled genetic perturbation screens with image-based phenotypes

查看全部

Sections

Figures

References

Organoid culture systems are self-renewing, three-dimensional (3D) models derived from pluripotent stem cells, adult derived stem cells or cancer cells that recapitulate key molecular and structural characteristics of their tissue of origin. They generall
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
References
ACKNOWLEDGMENTS
ACKNOWLEDGMENTS

Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009).
van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945 (2015).
Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338 (2015).
Vaes, R. D. W. et al. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. J. Cachexia Sarcopenia Muscle 11, 1509–1524 (2020).
Sachs, N. et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 38, e100300 (2019).
Schutgens, F. & Clevers, H. Human organoids: tools for understanding biology and treating diseases. Annu. Rev. Pathol. 15, 211–234 (2020).
Simian, M. & Bissell, M. J. Organoids: a historical perspective of thinking in three dimensions. J. Cell Biol. 216, 31–40 (2017).
Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597 (2016).
Romero-Calvo, I. et al. Human organoids share structural and genetic features with primary pancreatic adenocarcinoma tumors. Mol. Cancer Res. 17, 70–83 (2019).
Ščupáková, K., Dewez, F., Walch, A. K., Heeren, R. M. A. & Balluff, B. Morphometric cell classification for single-cell MALDI-mass spectrometry imaging. Angew. Chem. Int. Ed. Engl. 59, 17447–17450 (2020).
Aberle, M. R. et al. Patient-derived organoid models help define personalized management of gastrointestinal cancer. Br. J. Surg. 105, e48–e60 (2018).
Rocha, B. et al. Characterization of lipidic markers of chondrogenic differentiation using mass spectrometry imaging. Proteomics 15, 702–713 (2015).
Georgi, N. et al. Differentiation of mesenchymal stem cells under hypoxia and normoxia: lipid profiles revealed by time-of-flight secondary ion mass spectrometry and multivariate analysis. Anal. Chem. 87, 3981–3988 (2015).
Bakker, B. et al. Oxygen-dependent lipid profiles of three-dimensional cultured human chondrocytes revealed by MALDI-MSI. Anal. Chem. 89, 9438–9444 (2017).
Li, H. & Hummon, A. B. Imaging mass spectrometry of three-dimensional cell culture systems. Anal. Chem. 83, 8794–8801 (2011).
Ahlf Wheatcraft, D. R., Liu, X. & Hummon, A. B. Sample preparation strategies for mass spectrometry imaging of 3D cell culture models. J. Vis. Exp. https://doi.org/10.3791/52313 (2014).
Johnson, J., Sharick, J. T., Skala, M. C. & Li, L. Sample preparation strategies for high-throughput mass spectrometry imaging of primary tumor organoids. J. Mass Spectrom. https://doi.org/10.1002/jms.4452 (2019).
Ellis, S. R. et al. Automated, parallel mass spectrometry imaging and structural identification of lipids. Nat. Methods 15, 515–518 (2018).
Chughtai, K. & Heeren, R. M. Mass spectrometric imaging for biomedical tissue analysis. Chem. Rev. 110, 3237–3277 (2010).
Liu, X. & Hummon, A. B. Mass spectrometry imaging of therapeutics from animal models to three-dimensional cell cultures. Anal. Chem. 87, 9508–9519 (2015).
Porta Siegel, T. et al. Mass spectrometry imaging and integration with other imaging modalities for greater molecular understanding of biological tissues. Mol. Imaging Biol. 20, 888–901 (2018).
Zavalin, A., Yang, J. & Caprioli, R. Laser beam filtration for high spatial resolution MALDI imaging mass spectrometry. J. Am. Soc. Mass Spectrom. 24, 1153–1156 (2013).
Powers, T. W. et al. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Anal. Chem. 85, 9799–9806 (2013).
Judd, A. M. et al. A recommended and verified procedure for in situ tryptic digestion of formalin-fixed paraffin-embedded tissues for analysis by matrix-assisted laser desorption/ionization imaging mass spectrometry. J. Mass Spectrom. 54, 716–727 (2019).
Zubarev, R. & Mann, M. On the proper use of mass accuracy in proteomics. Mol. Cell Proteom. 6, 377–381 (2007).
Zubarev, R. A. & Makarov, A. Orbitrap mass spectrometry. Anal. Chem. 85, 5288–5296 (2013).
Barner-Kowollik, C., Gruendling, T., Falkenhagen, J. & Weidner, S. Mass Spectrometry in Polymer Chemistry 5–32 (Wiley-VCH, 2012).
Palzer, J. et al. Magnetic fluid hyperthermia as treatment option for pancreatic cancer cells and pancreatic cancer organoids. Int. J. Nanomed. 16, 2965–2981 (2021).
Broutier, L. et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat. Protoc. 11, 1724–1743 (2016).
Hansen, R. L. & Lee, Y. J. Overlapping MALDI-mass spectrometry imaging for in-parallel MS and MS/MS data acquisition without sacrificing spatial resolution. J. Am. Soc. Mass Spectrom. 28, 1910–1918 (2017).
OuYang, C., Chen, B. & Li, L. High throughput in situ DDA analysis of neuropeptides by coupling novel multiplex mass spectrometric imaging (MSI) with gas-phase fractionation. J. Am. Soc. Mass Spectrom. 26, 1992–2001 (2015).
Bokhart, M. T., Nazari, M., Garrard, K. P. & Muddiman, D. C. MSiReader v1.0: evolving open-source mass spectrometry imaging software for targeted and untargeted analyses. J. Am. Soc. Mass Spectrom. 29, 8–16 (2018).
Föll, M. C. et al. Accessible and reproducible mass spectrometry imaging data analysis in Galaxy. GigaScience https://doi.org/10.1093/gigascience/giz143 (2019).
Verbeeck, N., Caprioli, R. M. & Van de Plas, R. Unsupervised machine learning for exploratory data analysis in imaging mass spectrometry. Mass Spectrom. Rev. 39, 245–291 (2020).

Preparing ductal epithelial organoids for high-spatial-resolution molecular profiling using mass spectrometry imaging

Supplementary information

推荐阅读